Key facts
- This page summarizes Eliot M. Lurier's Form 3 filing for TENAX THERAPEUTICS, INC. (TENX).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 04 Nov 2021, 16:56.
Eliot M. Lurier - 29 Oct 2021 Form 3 Insider Report for TENAX THERAPEUTICS, INC. (TENX)
- Reporting relationship
- Interim CFO
- Issuer ticker
- TENX
- Reported as of
- 29 Oct 2021
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 04 Nov 2021, 16:56:08 UTC
- Next SEC filing
- 07 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ S. Halle Vakani, as Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eliot M. Lurier filed Form 3 for TENAX THERAPEUTICS, INC. (TENX) on 04 Nov 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TENX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 29 Oct 2021
- Ownership
- Direct
* marks a reported price that did not pass the local price check.